Prophylactic Antibiotics May Decrease Rate of Non-pancreatic Infection and UTI in Patients with Acute Pancreatitis
Background
Although several clinical trials and guidelines indicate that prophylactic antibiotics are not beneficial in preventing infected necrosis and reducing the incidence of complications and death, some physicians still choose to administer prophylactic antibiotics to patients with acute pancreatitis (AP). It is unclear whether prophylactic antibiotics are beneficial in AP to prevent infected necrosis and reduce the incidence of death.
Aim
To assess whether antibiotic prophylaxis is beneficial in patients with AP. Researchers focused not only on mortality and morbidity but also on specific infections such as pneumonia, urinary tract infection (UTI), positive blood culture, and fungal infection.
Patients Profile
Patients with AP or severe AP (SAP) or acute necrotizing pancreatitis
Methods
- The metanalysis included studies randomized control trials (11 RCTs) that
- Assessed prophylactic use of antibiotics
- written in any language
- comprised of patients (N=747 participants) with AP or SAP or acute necrotizing pancreatitis
- described the name and dose of antibiotics
- Randomized control trials
|
First authors |
Year |
Study design |
Clinical features |
Number of patients (intervention/ control), n |
Gender (male/ female) |
Antibiotics and dosage |
Time of administration (h) |
Antibiotic duration (days) |
Outcome∗ measures |
|
Dellinger et al |
2007 |
RCT (multicenter) |
Pancreatic necrosis on CT scan |
100 (50/50) |
70/30 |
Meropenem (1 g, q8h) |
<120 |
7–21 |
1,2,3,4 |
|
Garc?a-Barrasa et al |
2009 |
RCT (single-center) |
Pancreatic necrosis on CT scan |
41 (22/19) |
29/12 |
Ciprofloxacin (300 mg, q12h) |
48–72 |
10 |
1,2,3,4 |
|
Isenmann et al |
2004 |
RCT (multicenter) |
Pancreatic necrosis on CT scan; CRP > 150 mg/L |
114 (58/56) |
87/27 |
Ciprofloxacin (400 mg, q12h), metronidazole (500 mg, q12h) |
<72 |
14–21 |
1,2,3,4 |
|
Nordback et al |
2001 |
RCT (single-center) |
Pancreatic necrosis on CT scan |
58 (25/33) |
51/7 |
Imipenem (1 g, q8h) |
<48 |
Not stated |
1,2,3,4 |
|
Pederzoli et al |
1993 |
RCT (multicenter) |
Pancreatic necrosis on CT scan |
74 (41/33) |
Not stated |
Imipenem (0.5 g, q8h) |
<72 |
14 |
1,2,3,4 |
|
Poropat et al |
2016 |
RCT (single-center) |
Acute pancreatitis APACHE II score >8 |
47 (23/24) |
Not stated |
Imipenem (0.5 g, q8h) |
Not stated |
10 |
1,2,4 |
|
Poropat et al |
2017 |
RCT (single-center) |
Acute pancreatitis APACHE II score 8 |
98 (49/49) |
Not stated |
Imipenem (0.5 g, q8h) |
Not stated |
10 |
1, 4 |
|
Rokke et al |
2007 |
RCT (multicenter) |
Pancreatic necrosis on CT scan; CRP >120 mg/L (24 h); CRP |
73 (36/37) |
49/24 |
Imipenem (0.5 g, q8h) |
<72 |
5–7 |
1,2,3,4 |
|
Sainio et al |
1995 |
RCT (single-center) |
>240 mg/L (48 h) Low enhancement on CT; CRP >120 mg/L |
60 (30/30) |
53/7 |
Cefuroxime (1.5 g, q8h) |
<48 |
14 |
1,2,3 |
|
Schwarz et al |
1997 |
RCT (single-center) |
Pancreatic necrosis on CT scan |
26 (13/13) |
Not stated |
Ofloxacin (200 mg, q12h), metronidazole (500 mg, q12h) |
Not stated |
10 |
1, 2 |
|
Xue et al |
2009 |
RCT (single-center) |
>30% pancreatic necrosis on CT scan |
56 (29/27) |
28/28 |
Imipenem (0.5 g, q8h) |
<72 |
7–10 |
1,2,3,4 |
Meaning of numbers for outcome measures: 1: Death; 2: Infected pancreatic necrosis; 3: Surgical intervention; 4: Non-pancreatic infection; RCT: Randomized controlled trial; CT: Chemotherapy; CRP: C-reaction protein; APACHE II: Acute Physiology and Chronic Health Evaluation I.
- Pooled analyses for infected pancreatic necrosis, mortality, surgical intervention, and non-pancreatic infection
Outcomes
- Primary outcome parameters: the incidence of infected pancreatic necrosis and mortality
- Secondary outcome parameters: the incidence of surgical intervention, non-pancreatic infection, pneumonia, UTI, positive blood culture, and fungal infection
Results
- The intervention group included (prophylactic use of antibiotics, n = 376) and control group (n = 371).
Effect on the Incidence of infected Pancreatic necrosis and Mortality and Surgical Intervention
- No significant differences were found regarding antibiotic prophylaxis concerning the incidence of
- infected pancreatic necrosis (OR, 0.74; P = 0.13)
- surgical intervention (OR, 0.92; P = 0.70)
- morality (OR, 0.71; P = 0.16)
Effect on non-pancreatic infection Pneumonia, UTI, Positive blood culture, Fungal infection
- The use of antibiotics was associated with a significant reduction in the incidence of non-pancreatic infections.
- The overall OR was 0.59 (P = 0.004)
- Prophylactic use of antibiotics did not reduce the incidence of pneumonia (OR = 0.61; P = 0.12) ,positive blood culture (OR = 0.61; P = 0.20), or fungal infection (OR = 0.95; P = 0.94)
- However, antibiotic prophylaxis could reduce the incidence of UTI (OR = 0.44; P = 0.02)
Conclusions
- Prophylactic antibiotics can reduce the incidence of non-pancreatic infection and UTI in patients with AP
- Prophylactic antibiotics did not reduce rate of infected pancreatic necrosis, mortality, surgical intervention, pneumonia, positive blood culture, and fungal infection.
Reference
Chinese Medical Journal 2020; 133;2: 213-220









